These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 14740074)
21. Lipid abnormalities in insulin resistant states. Watson KE; Horowitz BN; Matson G Rev Cardiovasc Med; 2003; 4(4):228-36. PubMed ID: 14668690 [TBL] [Abstract][Full Text] [Related]
22. Endothelial dysfunction and type 2 diabetes. Part 1: physiology and methods for exploring the endothelial function. Guerci B; Kearney-Schwartz A; Böhme P; Zannad F; Drouin P Diabetes Metab; 2001 Sep; 27(4 Pt 1):425-34. PubMed ID: 11547216 [TBL] [Abstract][Full Text] [Related]
23. [Role of insulin resistance in diabetes mellitus and other risk factors for cardiovascular diseases]. Tack CJ; Smits P; Lutterman JA Ned Tijdschr Geneeskd; 1992 Aug; 136(35):1697-701. PubMed ID: 1407112 [No Abstract] [Full Text] [Related]
24. The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance. Kendall DM; Harmel AP Am J Manag Care; 2002 Dec; 8(20 Suppl):S635-53; quiz S654-7. PubMed ID: 12510788 [TBL] [Abstract][Full Text] [Related]
26. Chromium deficiency might contribute to insulin resistance, type 2 diabetes mellitus, dyslipidaemia, and atherosclerosis. Mahdi GS Diabet Med; 1996 Apr; 13(4):389-90. PubMed ID: 9162617 [No Abstract] [Full Text] [Related]
27. Role of insulin resistance in human disease (syndrome X): an expanded definition. Reaven GM Annu Rev Med; 1993; 44():121-31. PubMed ID: 8476236 [TBL] [Abstract][Full Text] [Related]
28. Insulin resistance and its impact on the approach to therapy of type 2 diabetes. Laakso M Int J Clin Pract Suppl; 2001 Sep; (121):8-12. PubMed ID: 11594246 [TBL] [Abstract][Full Text] [Related]
29. Role of endothelial dysfunction in insulin resistance. Hsueh WA; Quiñones MJ Am J Cardiol; 2003 Aug; 92(4A):10J-17J. PubMed ID: 12957322 [TBL] [Abstract][Full Text] [Related]
31. [Assessment of selected markers of inflammation in patients with clinical symptoms of insulin resistance and normal renal function]. Bogdański P; Pupek-Musialik D; Luczak M; Szulińska M Pol Merkur Lekarski; 2006 Aug; 21(122):165-8; discussion 169. PubMed ID: 17144103 [TBL] [Abstract][Full Text] [Related]
32. The insulin resistance syndrome: impact on lipoprotein metabolism and atherothrombosis. Ginsberg HN; Huang LS J Cardiovasc Risk; 2000 Oct; 7(5):325-31. PubMed ID: 11143762 [TBL] [Abstract][Full Text] [Related]
33. Essential hypertension, metabolic disorders, and insulin resistance. Ferrannini E; Natali A Am Heart J; 1991 Apr; 121(4 Pt 2):1274-82. PubMed ID: 2008856 [TBL] [Abstract][Full Text] [Related]
34. [Dyslipoproteinemia and metabolic syndrome. Effects of insulin resistance and hyperinsulinemia on lipid metabolism]. Krone W; Müller-Wieland D; Wirth H Fortschr Med; 1992 Dec; 110(34):645-8. PubMed ID: 1483617 [TBL] [Abstract][Full Text] [Related]
35. The vascular biology of atherosclerosis. Plutzky J Am J Med; 2003 Dec; 115 Suppl 8A():55S-61S. PubMed ID: 14678867 [TBL] [Abstract][Full Text] [Related]
36. The insulin resistance syndrome. Smolar EN Compr Ther; 1997 Apr; 23(4):237-43. PubMed ID: 9167914 [No Abstract] [Full Text] [Related]
37. Insulin resistance: a risk marker for disease and disability in the older person. Krentz AJ; Viljoen A; Sinclair A Diabet Med; 2013 May; 30(5):535-48. PubMed ID: 23173973 [TBL] [Abstract][Full Text] [Related]
38. Should patients with type 2 diabetes asymptomatic for coronary artery disease undergo testing for myocardial ischemia? O'Rourke RA Nat Clin Pract Cardiovasc Med; 2005 Oct; 2(10):492-3. PubMed ID: 16186827 [No Abstract] [Full Text] [Related]
39. Born small for gestational age: increased risk of type 2 diabetes, hypertension and hyperlipidaemia in adulthood. Jaquet D; Czernichow P Horm Res; 2003; 59 Suppl 1():131-7. PubMed ID: 12638526 [TBL] [Abstract][Full Text] [Related]